Skip to content
Hybrick Logo

Boston vs. Berlin

3 lessons to learn from the Global Biotech Capital

Boston vs Berlin2

Foto: Boston |ย ยฉ Unsplashย 

Berlin is home to a strong Life Sciences ecosystem, characterized by excellent research institutions, innovative companies, and a collaborative environment. But especially commercialization and scaling is where Boston sets the global benchmark.

๐—ช๐—ต๐—ฎ๐˜ ๐˜€๐—ฒ๐˜๐˜€ ๐—•๐—ผ๐˜€๐˜๐—ผ๐—ป ๐—ฎ๐—ฝ๐—ฎ๐—ฟ๐˜ โ€” ๐—ฎ๐—ป๐—ฑ ๐˜„๐—ต๐—ฒ๐—ฟ๐—ฒ ๐—ฐ๐—ฎ๐—ป ๐—•๐—ฒ๐—ฟ๐—น๐—ถ๐—ป ๐—ฎ๐—ฑ๐—ฎ๐—ฝ๐˜?

โ†’ ๐—ฆ๐˜๐—ฟ๐—ผ๐—ป๐—ด๐—ฒ๐—ฟ ๐—ฐ๐—น๐˜‚๐˜€๐˜๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ผ๐—ผ๐—ฝ๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐—ณ๐—ฟ๐—ฎ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป
By pooling talent, startups, and capital, Boston has created a dense innovation ecosystem. In contrast, Berlinโ€™s innovation landscape is spread across many individual locations that often do not have a common strategy. Efforts should now focus on bundling resources and building stronger connections between research, startups, and investors.

โ†’ ๐—ฆ๐—ฐ๐—ฎ๐—น๐—ฒ-๐˜‚๐—ฝ ๐—ฐ๐—ฎ๐—ฝ๐—ถ๐˜๐—ฎ๐—น ๐—ถ๐˜€ ๐—ฐ๐—ฟ๐˜‚๐—ฐ๐—ถ๐—ฎ๐—น
Bostonโ€™s success rests not just on seed funding but late-stage venture capital. In Germany, this remains the critical gap. As a result, many companies relocate or are acquired โ€” a partly natural market dynamic but often leading to a loss of expertise and innovation.
Berlin has made a strong start by launching a โ‚ฌ10 million pre-seed VC fund to support deep tech science spin-offs โ€” but closing the scale-up gap will require much larger growth capital initiatives.

โ†’ ๐—–๐˜‚๐—น๐˜๐—ถ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—ฎ๐—ป ๐—ฒ๐—ป๐˜๐—ฟ๐—ฒ๐—ฝ๐—ฟ๐—ฒ๐—ป๐—ฒ๐˜‚๐—ฟ๐—ถ๐—ฎ๐—น ๐—บ๐—ถ๐—ป๐—ฑ๐˜€๐—ฒ๐˜ ๐—ฎ๐—ป๐—ฑ ๐—ธ๐—ฒ๐—ฒ๐—ฝ๐—ถ๐—ป๐—ด ๐˜๐—ฎ๐—น๐—ฒ๐—ป๐˜
Boston embedded entrepreneurship into academic culture. In Berlin, more researchers are transitioning into founders, but the momentum can still accelerate. Talent retention through attractive infrastructure and entrepreneurial incentives โ€” as well as reducing bureaucratic hurdles โ€” is essential.

___
๐—•๐—ผ๐˜๐˜๐—ผ๐—บ ๐—น๐—ถ๐—ป๐—ฒ: Deeper collaboration, later-stage capital, and cultural change are essential to unlock the full potential of Germanyโ€™s biotech hubs.

With the new 2025 Coalition Agreement officially identifying Life Sciences and Deep Tech as national growth priorities, the mission to strengthen entrepreneurship, attract talent, and close the scale-up funding gap has been set.

๐—ง๐—ต๐—ฒ ๐—ณ๐—ผ๐—ฐ๐˜‚๐˜€ ๐—ป๐—ผ๐˜„ ๐˜€๐—ต๐—ถ๐—ณ๐˜๐˜€ ๐˜๐—ผ ๐—ถ๐—บ๐—ฝ๐—น๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป โ€” ๐—ฎ๐—ป๐—ฑ ๐˜„๐—ฒ ๐—น๐—ผ๐—ผ๐—ธ ๐—ณ๐—ผ๐—ฟ๐˜„๐—ฎ๐—ฟ๐—ฑ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—ป๐—ฒ๐˜…๐˜ ๐˜€๐˜๐—ฒ๐—ฝ๐˜€, ๐—ฒ๐˜€๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ฎ๐—น๐—น๐˜† ๐—ถ๐—ป ๐—•๐—ฒ๐—ฟ๐—น๐—ถ๐—ป.

You want to know more? Click here.

Alle Updates direkt auf LinkedIn verfolgen und mitdiskutieren.